Basic Science Foundations of Dermatology
What to master
Basic dermatology questions reward a structural, layered view of skin. Know the epidermal maturation sequence (basal → spinous → granular → cornified), the meaning of orthokeratosis versus parakeratosis, and which cells sit where (melanocytes in the basal layer, Langerhans cells in the spinous layer, Merkel cells at the basal layer). In the dermis, separate papillary from reticular collagen and recall that elastic fibers (elastin, fibrillin) and ground substance (hyaluronan, dermatan sulfate) determine skin mechanics. The basement membrane zone is a favorite: hemidesmosomes (BPAG1/BPAG2), lamina lucida, lamina densa, and anchoring fibrils (type VII collagen) map directly onto bullous disease targets.
Immunology and biology
Understand the skin as an immune organ: keratinocyte-derived cytokines, Toll-like receptor signaling, and the Th1/Th2/Th17 axis that explains why biologics target specific cytokines. Wound healing phases (hemostasis, inflammation, proliferation, remodeling) and the role of TGF-beta in scarring are commonly tested.
Traps
Questions often confuse type IV collagen (basement membrane) with type VII (anchoring fibrils), or ask which layer contains melanocytes when the distractor is the granular layer. Another trap: parakeratosis implies retained nuclei and often incomplete keratinization, not simply "thick stratum corneum." Watch for questions that swap keratin types (K5/K14 in basal cells; K1/K10 suprabasal).
Rule of thumb
Anchor every blister to its level: intraepidermal (pemphigus), subepidermal lamina lucida (bullous pemphigoid), or sublamina densa (epidermolysis bullosa dystrophica). The level predicts the clinical fragility and the immunofluorescence pattern.
Worked example
A question describes tense blisters with linear IgG at the basement membrane. Tense = subepidermal; linear IgG at BMZ = bullous pemphigoid targeting BPAG2 (BP180). If it described flaccid blisters with intercellular IgG, the answer shifts to pemphigus vulgaris (desmoglein 3).